Medizone International, Inc. (OTCMKTS:MZEI) Files An 8-K Other Events
Item 8.01 Other Events.
announced it had entered into a commissioned sales agreement with
Innovasource LLC for the promotion and sale of AsepticSure,
Registrants patented disinfection technology that combines ozone
and hydrogen peroxide to combat bacterial and viral pathogens.
The Registrant issued a press release on April 24, 2017
disclosing the agreement. A copy of the press release is attached
as Exhibit 99.1.
|
Exhibit Number
|
Description
|
|
|
99.1
|
Press Release dated April 24, 2017.
|
About Medizone International, Inc. (OTCMKTS:MZEI)
Medizone International, Inc. is engaged in designing, manufacturing and selling a system using ozone in the disinfection of surgical and other medical treatment facilities and in other applications. The Company’s AsepticSure is an ozone-based technology, which is used for the purpose of decontaminating and disinfecting hospital surgical suites, emergency rooms, intensive care units and other enclosed spaces, such as gym locker rooms, laboratories and veterinary clinics. In the AsepticSure system, oxygen atoms are misted into the environment with a hydrogen peroxide vapor and the system’s formula creates Trioxidane. The Company is developing a variant of AsepticSure for governmental use with bio-terrorism countermeasures. AsepticSure has completed safety and preliminary operational trials. During the tests, AsepticSure has demonstrated a turnaround time of approximately 90 minutes for disinfection and reoccupation of the hospital rooms. Medizone International, Inc. (OTCMKTS:MZEI) Recent Trading Information
Medizone International, Inc. (OTCMKTS:MZEI) closed its last trading session down -0.0050 at 0.0800 with 39,639 shares trading hands.